IQE PLC
22 October 2026
IQE plc
Cardiff, UK
22 October 2026
Exercise of Warrants, Issue of Equity and TVR
IQE plc (AIM: IQE, "IQE" or the "Group"), the leading global supplier of compound semiconductor wafer products and advanced material solutions, announces that Mark Cubitt, Non-Executive Chair, has given notice to exercise warrants held over 1,709,803 ordinary shares of 1 pence each ("Ordinary Shares") in the capital of the Company at an exercise price of 13.5 pence per share.
Following the exercise of the warrants, Mark Cubitt will hold 3,005,108 Ordinary Shares representing 0.23% of the issued share capital.
Admission and Total Voting Rights
Application has been made to the London Stock Exchange for Admission of the 1,709,803 Ordinary Shares to trading on AIM ("Admission"). It is expected that Admission will become effective on or around 27 October 2026.
The Ordinary Shares will be issued fully paid and will rank pari passu in all respects with the Company's existing Ordinary Shares.
Following Admission, the total number of Ordinary Shares in the capital of the Company in issue will be 1,332,837,130 with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's issued share capital.
Contacts:
IQE plc
+44 (0) 29 2083 9400
Jutta Meier
Mark Cubitt
Amy Barlow
Peel Hunt (Nomad and Joint Broker)
+44 (0) 20 7418 8900
Ben Cryer
Kate Bannatyne
Adam Telling
Deutsche Numis (Joint Broker)
+44 (0) 20 7260 1000
Simon Willis
Hugo Rubinstein
Iqra Amin
Headland Consultancy (Financial PR) + 44 (0) 20 38054822
Andy Rivett-Carnac: +44 (0) 7968 997 365
Chloe Francklin: +44 (0)78 3497 4624
ABOUT IQE
IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions. IQE's technologies enable high-performance devices across a diverse range of end markets including:
· AI & datacentre
· Consumer electronics
· Communications infrastructure
· Aerospace and defence
· Automotive and industrial
IQE combines more than 35 years of specialist expertise with a broad technology portfolio and a global manufacturing footprint across the UK, US and Taiwan, supporting customers from innovation through to high-volume production.
IQE is headquartered in Cardiff, UK, and is listed on the AIM-market of the London Stock Exchange.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1. |
Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") |
|
|
a) |
Name |
Mark Cubitt |
|
2. |
Reason for the notification |
|
|
a) |
Position / status |
PDMR (Non-Executive Chair) |
|
b) |
Initial notification / amendment |
Initial notification |
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
IQE plc |
|
b) |
Legal Entity Identifier |
213800Y33WHD3ESJJP16 |
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Warrants to subscribe for ordinary shares of 1 pence each in the Company |
|
b) |
Nature of the transaction |
Exercise of warrants to subscribe for 1,709,803 ordinary shares of 1 pence each in the Company |
|
c) |
Price(s) and volume(s) |
1,709,803 ordinary shares at an issue price of 13.5 pence per share (as adjusted in accordance with the warrant conditions) |
|
d) |
Aggregated information · Aggregated volume · Aggregated price |
|
|
e) |
Date of the transaction(s) |
21 October 2026 |
|
f) |
Place of the transaction |
Off-market |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.